Kiniksa Pharmaceuticals International, plc Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Kiniksa Pharmaceuticals International, plc Earnings Per Share, Basic for the quarter ending September 30, 2025 was 0.25 USD/shares.
  • Kiniksa Pharmaceuticals International, plc Earnings Per Share, Basic for the twelve months ending September 30, 2025 was 0 USD/shares.
  • Kiniksa Pharmaceuticals International, plc annual Earnings Per Share, Basic for 2024 was -0.6 USD/shares, a 400% decline from 2023.
  • Kiniksa Pharmaceuticals International, plc annual Earnings Per Share, Basic for 2023 was 0.2 USD/shares, a 92.4% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Earnings Per Share, Basic for 2022 was 2.64 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Kiniksa Pharmaceuticals International, plc Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0.25 +$0.43 Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 $0 $0.24 +$0.30 Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 $0 $0.12 +$0.37 Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q4 2024 $0 $0 $0 -130% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $0 $0 +$0.02 +10% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 $0 $0 $0 -129% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 $0 $0 $0 -38.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q4 2023 $0 $0.37 +$0.31 +517% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 $0 $0 -$3 -106% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $3.00 $0.21 +$0.50 Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $2.00 $0 +$0.18 +50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $2.00 $0.06 +$0.59 Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 $2.00 $3.23 +$3.67 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$1 $0 +$0.32 +52.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$1 $0 +$0.36 +50% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$2 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05

Kiniksa Pharmaceuticals International, plc Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 -$1 -400% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $0.20 -$2 -92.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $2.64 +$4.94 Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$2 +$0.31 +11.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$3 +$0.38 +12.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$3 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.